Physician profile
David Ng
NPI 1134313372
$874.16
in general payments reported to CMS, 2019-2025
8 companies · $289 in 2025
The $289 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.81 · 2023: $116 · 2024: $432 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539 · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.35 |
| Education | $298.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $379.88 | 2023-2024 | Prialt |
| Electromed, INC. | $210.11 | 2024-2025 | Smartvest |
| Heartflow, INC. | $66.91 | 2024-2025 | |
| Curonix LLC | $65.90 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Glaxosmithkline, LLC. | $60.85 | 2019-2025 | Nucala |
| Relievant Medsystems, INC. | $40.34 | 2023 | Intracept |
| Nalu Medical, INC. | $35.02 | 2025 | Nalu Neurostimulation System |
| Mml US, INC. | $15.15 | 2023 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.